Sean Whelan

Director/Board Member chez ZOMEDICA CORP. Fortune : 12 125 $ au 31/03/2024

Profil

Sean M.
Whelan currently works at Zomedica Corp., as Independent Director from 2021 and Optio RX LLC, as Director from 2019.
Mr. Whelan also formerly worked at Encore Rehabilitation Services LLC, as Chief Executive Officer, SPAR Group, Inc., as Independent Director from 2021 to 2023, Automotive Components Holdings LLC, as Accounting Director from 2005 to 2007, Diplomat Pharmacy, Inc., as CFO, Secretary, Treasurer & Director from 2010 to 2016, ReachOut Healthcare America Ltd., as Chief Financial Officer from 2019 to 2020, InfuSystem Holdings, Inc., as Chief Financial Officer & Head-Investor Relations in 2010, Deloitte & Touche LLP, as Senior Auditor from 1992 to 1995, Diplomat Pharmacy, Inc., as Secretary & Treasurer in 2016, Energiz Renewable, Inc., as Vice President-Investments, and Bedrock Manufacturing Co. LLC, as Chief Financial Officer from 2018 to 2019.
Mr. Whelan received his undergraduate degree and graduate degree from Stephen M.
Ross School of Business.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
SPAR GROUP, INC. 0,05%	31/12/2022	12 500 ( 0,05% )	12 125 $	31/03/2024

Postes actifs de Sean Whelan

Sociétés	Poste	Début
ZOMEDICA CORP.	Director/Board Member	13/09/2021
Optio RX LLC	Director/Board Member	01/01/2019

Anciens postes connus de Sean Whelan

Sociétés	Poste	Fin
SPAR GROUP, INC.	Director/Board Member	30/09/2023
ReachOut Healthcare America Ltd.	Director of Finance/CFO	01/01/2020
Bedrock Manufacturing Co. LLC	Director of Finance/CFO	01/01/2019
DIPLOMAT PHARMACY, INC.	Director of Finance/CFO	31/12/2016
DIPLOMAT PHARMACY, INC.	Director of Finance/CFO	01/01/2016

Formation de Sean Whelan

Stephen M. Ross School of Business

Graduate Degree